 Summary of this article
- Tamil Nadu bans Coldrif cough syrup from October 1 following reports of child deaths.
- Samples collected from the manufacturer are being tested for toxic chemicals.
- Union Health Ministry advises against prescribing cough medicine to children under two.
The Tamil Nadu government has banned the sale of the cough syrup ‘Coldrif’ and ordered its removal from the market following reports linking the medicine to the deaths of 11 children in Madhya Pradesh and Rajasthan.
According to PTI, the Food Safety and Drug Administration Department (FDA) in Tamil Nadu announced that, with effect from October 1, the sale of the syrup manufactured by a city-based firm has been prohibited across the state.
Officials said inspections were conducted at the company’s manufacturing facility in Sunguvarchathram, Kancheepuram district, over the past two days, and samples of the syrup were collected for laboratory testing. The samples will be analysed for the presence of diethylene glycol, a chemical suspected to be linked to the deaths, PTI reported.
The Contaminated Syrup Tragedy In Jammu And Kashmir’s Ramnagar
BY Naseer Ganai |
